Description
Azista Industries manufactures Paxista®, a generic version of Pfizer’s Paxlovid. Paxlovid, developed by Pfizer, is the first FDA-approved oral therapy for covid-19 treatment in the United States. Paxista contains the same Nirmatrelvir Inn 150 mg and Ritonavir USP 100 mg as Pfizer’s Paxlovid. Paxista reduces the risk of hospitalization or death by a significant amount. Under a EUA, the FDA has approved PAXLOVID for the treatment of mild-to-moderate COVID-19 in adults and children [12 years of age and older, weighing at least 88 pounds (40 kg)] who have a positive test for the virus that causes COVID-19 and are at high risk of severe COVID-19, including hospitalization or death.Even if Paxista isn’t approved in your country, it can be made available through the EUA. Paxista is effective against all Delta and Omicron variants.
Send your inquiry now to learn more about Paxista – a generic Paxlovid manufactured by Azista Industries.
Reviews
There are no reviews yet.